Drug Resistance in Hematological Malignancies

doi:10.3390/ijms21176091

Article

Drug Resistance in Hematological Malignancies

24 Aug 2020

Abstract excerpt

Hematological malignancies define a highly heterogeneous set of blood-, bone marrow-, and organ-associated diseases with highly variable prognoses that constantly relapse upon treatment [...].

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.